Modera Wealth Management’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-30,513
Closed -$176K 605
2024
Q2
$176K Hold
30,513
﹤0.01% 554
2024
Q1
$363K Hold
30,513
0.01% 443
2023
Q4
$571K Hold
30,513
0.01% 358
2023
Q3
$290K Hold
30,513
0.01% 461
2023
Q2
$436K Hold
30,513
0.01% 401
2023
Q1
$470K Hold
30,513
0.02% 223
2022
Q4
$410K Hold
30,513
0.02% 233
2022
Q3
$418K Sell
30,513
-400
-1% -$5.26K 0.02% 205
2022
Q2
$351K Sell
30,913
-400
-1% -$4.37K 0.02% 235
2022
Q1
$418K Sell
31,313
-1,000
-3% -$14.4K 0.02% 229
2021
Q4
$568K Sell
32,313
-985
-3% -$25.4K 0.02% 254
2021
Q3
$1.06M Sell
33,298
-1,448
-4% -$83.3K 0.05% 102
2021
Q2
$2.97M Sell
34,746
-5,900
-15% -$273K 0.16% 55
2021
Q1
$1.13M Sell
40,646
-3,200
-7% -$68.5K 0.07% 88
2020
Q4
$331K Buy
+43,846
New +$237K 0.03% 170

Other funds holding ANVS

Modera Wealth Management's ANVS Position: Q3 2024 in Review

Modera Wealth Management sold out of Annovis Bio (ANVS) in Q3 2024, closing a stake of 30,513 shares — an estimated $176K sold.

Modera Wealth Management first reported a position in ANVS in Q4 2020 and held it in 15 quarters. The position peaked at $2.97M in Q2 2021. 35 funds tracked by Wall St. Rank hold ANVS as of Q3 2024.

  • Modera Wealth Management reported no remaining Annovis Bio position as of Q3 2024 after selling out during the quarter.
  • Modera Wealth Management sold 30,513 Annovis Bio shares in Q3 2024, an estimated $176K.
  • Modera Wealth Management first reported a position in Annovis Bio in Q4 2020 and held it in 15 quarters.
  • Modera Wealth Management's Annovis Bio position peaked at $2.97M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2024.

Based on Modera Wealth Management's 13F filing for Q3 2024, filed 24 Oct 2024.